时间标签：数据日期 2026-11-01 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31–2026/11/01 ｜ 情报发生日期 2026-11-01
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
Calycosin-7-O-β-D-glucoside (CAG) has antioxidant and mitochondria-protective properties, but its therapeutic potential in TBI remains unclear.
方法
Calycosin-7-O-β-D-glucoside (CAG) has antioxidant and mitochondria-protective properties, but its therapeutic potential in TBI remains unclear.
核心结论
The present study demonstrated that CAG significantly improved neurological, behavioral, and cognitive outcomes in mice with controlled cortical impact (CCI)-induced TBI, while alleviating histopathological damage, neuronal apoptosis, glial activation, and…；Consistently, in H2O2-treated HT22 cells, CAG reduced oxidative stress, mitochondrial dysfunction, and apoptosis.；Mechanistically, transcriptomic, protein, and confocal immunofluorescence analyses showed that CAG reduced aberrant cGAS-STING signaling and attenuated abnormal subcellular redistribution of activated STING.；In parallel, CAG restored mitochondrial dynamics, with a reduced p-DRP1 (Ser616)/DRP1 ratio and increased MFN1, MFN2, and OPA1 expression.
局限
（原文未给出可直接抽取的对应表述）
对本项目的价值
临床前机制证据，需评估物种外推与剂量可行性：神经退行是长寿干预最难攻的终点，本文提供机制或生物标志物层面的抓手。 ｜ 价值分 1.7/5（★★☆☆☆）
全文来源
未取到全文 → 本卡为摘要级解读，未核验全文
原文题录
- 英文标题：Calycosin-7-O-β-D-glucoside alleviates neurological injury after traumatic brain injury: involvement of cGAS-STING signaling and mitochondrial dynamics.
- 期刊与标识：European journal of pharmacology · PMID 42956920 · DOI 10.1016/j.ejphar.2026.179495
B 级证据分级：B 级（同行评议临床前研究，主要为动物模型）
本文核心结论来自动物模型或体外细胞学，属临床前证据，不能外推至人体。「延长健康寿命」「改善功能」等表述在小鼠中的意义，与人类临床结局之间仍有距离。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。